The Prostate Pod

David James, Director of Patient Projects and Influencing at PCR talks to host Ben Monro-Davies about the National Screening Committee's draft recommendation that only those men who carry a BRCA1 or BRCA2 gene variant will be offered screening and what PCR will be doing next to ensure high-risk men get the early diagnosis they deserve.

David James, Director of Patient Projects and Influencing at PCR talks to host Ben Monro-Davies about Prostate Progress, PCR's most ambitiousproject, answering audience questions and the latest on the campaign for a national screening programme.    

Support Prostate Progress and double your donation between midday2nd December - 9th December 2025, visit https://donate.biggive.org/campaign/a05WS000006FrOlYAK

PCR researchers Dr Toby Phesse and Dr Helen Pearson chat to Ben about their research project investigating whether blocking certain signals in the body can stop prostate cancer from spreading to other parts of the body.

This episode, we meet Dr Anna Wilkins whose PCR project is looking at using AI to predict whether an individual's cancer will return. She chats to host Ben Monro-Davies about the project and being part of PCR.

Dr Claire Fletcher talks to host Ben Monro-Davies about her PCR-funded research looking at the link between obesity and prostate cancer.

Robin chats to host Ben Munro-Davies about his experiences of living with prostate cancer. From being diagnosed in 2015 to being on active surveillance to working with PCR as a patient representative.

In this episode, host Ben Monro-Davies is joined by Dr Kirsteen Campbell from the Beatson Institute in Glasgow. Kirsteen talks about her PCR research project exploring the role of MCL-1, a molecule found at high levels in people with advanced prostate cancer, what it could mean for prostate cancer patients in the future and why this funding from PCR was so critical.

Host Ben Munro-Davies catches up with Professor Colin Cooper, Chair of the PCR Scientific Committee, on the changes and progress which have happened in prostate cancer research and treatment over the past couple of decades, the pitfalls of PSA screening, and why we still need good ideas.

PCR patient representative, Neal chats to host Ben Munro-Davies about his experiences since receiving a diagnosis of advanced prostate cancer in 2018. From navigating side effects from treatment to working with PCR to build a future in which no family will have to fear losing a loved one to prostate cancer.

This episode, we meet Dan Brewer and Dan Woodcock, for a chat about how artificial intelligence is a new frontier against prostate cancer.